<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Valeant Pharmaceuticals: Difference between revisions - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.25wmf21" />
<meta name="robots" content="noindex,nofollow" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Valeant_Pharmaceuticals" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/w/index.php?diff=630575249&amp;oldid=628670703" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.rtlcite%2Cwikihiero%2CwikimediaBadges%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=mediawiki.action.history.diff&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Valeant_Pharmaceuticals","wgTitle":"Valeant Pharmaceuticals","wgCurRevisionId":651957776,"wgRevisionId":630575249,"wgArticleId":2350163,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["S\u0026P/TSX 60 Index","S\u0026P/TSX Composite Index","Companies listed on the Toronto Stock Exchange","Pharmaceutical companies of Canada","Companies listed on the New York Stock Exchange","Companies based in Laval, Quebec","Pharmaceutical companies established in 1960"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Valeant_Pharmaceuticals","wgRelevantArticleId":2350163,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr"},"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q1700871"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});},{},{},{});mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});},{},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:94007ea073e20ad4a3cdce36b2f2e369 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.25wmf21/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Valeant_Pharmaceuticals skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Valeant Pharmaceuticals: Difference between revisions</h1>
						<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class='diff diff-contentalign-left'>
				<col class='diff-marker' />
				<col class='diff-content' />
				<col class='diff-marker' />
				<col class='diff-content' />
				<tr style='vertical-align: top;'>
				<td colspan='2' class='diff-otitle'><div id="mw-diff-otitle1"><strong><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;oldid=628670703" title="Valeant Pharmaceuticals">Revision as of 16:32, 7 October 2014</a> <span class="mw-diff-edit">(<a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=edit&amp;oldid=628670703" title="Valeant Pharmaceuticals">edit</a>)</span></strong></div><div id="mw-diff-otitle2"><a href="/wiki/User:Derek_R_Bullamore" title="User:Derek R Bullamore" class="mw-userlink">Derek R Bullamore</a> <span class="mw-usertoollinks">(<a href="/wiki/User_talk:Derek_R_Bullamore" title="User talk:Derek R Bullamore">talk</a> | <a href="/wiki/Special:Contributions/Derek_R_Bullamore" title="Special:Contributions/Derek R Bullamore">contribs</a>)</span></div><div id="mw-diff-otitle3"> <span class="comment">(Filled in 23 reference(s) with <a href="/wiki/User:Zhaofeng_Li/Reflinks" class="mw-redirect" title="User:Zhaofeng Li/Reflinks">User:Zhaofeng Li/Reflinks</a>)</span></div><div id="mw-diff-otitle5"></div><div id="mw-diff-otitle4"><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;diff=prev&amp;oldid=628670703" title="Valeant Pharmaceuticals" id="differences-prevlink">← Previous edit</a></div></td>
				<td colspan='2' class='diff-ntitle'><div id="mw-diff-ntitle1"><strong><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;oldid=630575249" title="Valeant Pharmaceuticals">Revision as of 22:09, 21 October 2014</a> <span class="mw-diff-edit">(<a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=edit&amp;oldid=630575249" title="Valeant Pharmaceuticals">edit</a>)</span> <span class="mw-diff-undo">(<a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=edit&amp;undoafter=628670703&amp;undo=630575249" title="&quot;Undo&quot; reverts this edit and opens the edit form in preview mode. It allows adding a reason in the summary.">undo</a>)</span></strong></div><div id="mw-diff-ntitle2"><a href="/wiki/Special:Contributions/205.211.133.128" title="Special:Contributions/205.211.133.128" class="mw-userlink mw-anonuserlink">205.211.133.128</a> <span class="mw-usertoollinks">(<a href="/wiki/User_talk:205.211.133.128" title="User talk:205.211.133.128">talk</a>)</span> </div><div id="mw-diff-ntitle3"> <span class="comment">(<a href="#Mergers_and_acquisitions">→</a>‎<span dir="auto"><span class="autocomment">Mergers and acquisitions</span></span>)</span></div><div id="mw-diff-ntitle5"></div><div id="mw-diff-ntitle4"><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;diff=next&amp;oldid=630575249" title="Valeant Pharmaceuticals" id="differences-nextlink">Next edit →</a></div></td>
				</tr><tr>
  <td colspan="2" class="diff-lineno">Line 27:</td>
  <td colspan="2" class="diff-lineno">Line 27:</td>
</tr>
<tr>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"><div>'''2008'''</div></td>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"><div>'''2008'''</div></td>
</tr>
<tr>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"></td>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"></td>
</tr>
<tr>
  <td class="diff-marker">−</td>
  <td class="diff-deletedline"><div>In September, Valeant acquired [[Coria Laboratories, Ltd]] for $95 million, acquiring the outstanding shares from Corias parent company [[DFB Pharmaceuticals, Inc.]]&lt;ref&gt;{{cite web|url=http://ir.valeant.com/investor-relations/news-releases/news-release-details/2008/Valeant-Pharmaceuticals-Signs-Agreement-to-Acquire-Coria-Laboratories-Ltd/default.aspx|title=Valeant - Valeant Pharmaceuticals Signs Agreement to Acquire Coria Laboratories, Ltd.|publisher=Ir.valeant.com|accessdate=7 October 2014}}&lt;/ref&gt; In November, Valeant acquired [[DermaTech]] for about $12.6 million.&lt;ref&gt;{{cite web|url=http://www.genengnews.com/gen-news-highlights/valeant-pharmaceuticals-acquires-dermatech-for-12-6m/45513163/?kwrd=valeant%20acquires|title=GEN - News Highlights: Valeant Pharmaceuticals Acquires DermaTech for $12.6M|work=GEN|accessdate=7 October 2014}}&lt;/ref&gt; In December Valeant announced <del class="diffchange diffchange-inline">there</del> acquisition of [[Dow Pharmaceutical Sciences, Inc]] for $285 million.&lt;ref&gt;{{cite web|url=http://ir.valeant.com/investor-relations/news-releases/news-release-details/2008/Valeant-to-Acquire-Dow-Pharmaceutical-Sciences-Inc-for-285-Million/default.aspx|title=Valeant - Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million|publisher=Ir.valeant.com|accessdate=7 October 2014}}&lt;/ref&gt;</div></td>
  <td class="diff-marker">+</td>
  <td class="diff-addedline"><div>In September, Valeant acquired [[Coria Laboratories, Ltd]] for $95 million, acquiring the outstanding shares from Corias parent company [[DFB Pharmaceuticals, Inc.]]&lt;ref&gt;{{cite web|url=http://ir.valeant.com/investor-relations/news-releases/news-release-details/2008/Valeant-Pharmaceuticals-Signs-Agreement-to-Acquire-Coria-Laboratories-Ltd/default.aspx|title=Valeant - Valeant Pharmaceuticals Signs Agreement to Acquire Coria Laboratories, Ltd.|publisher=Ir.valeant.com|accessdate=7 October 2014}}&lt;/ref&gt; In November, Valeant acquired [[DermaTech]] for about $12.6 million.&lt;ref&gt;{{cite web|url=http://www.genengnews.com/gen-news-highlights/valeant-pharmaceuticals-acquires-dermatech-for-12-6m/45513163/?kwrd=valeant%20acquires|title=GEN - News Highlights: Valeant Pharmaceuticals Acquires DermaTech for $12.6M|work=GEN|accessdate=7 October 2014}}&lt;/ref&gt; In December Valeant announced <ins class="diffchange diffchange-inline">their</ins> acquisition of [[Dow Pharmaceutical Sciences, Inc]] for $285 million.&lt;ref&gt;{{cite web|url=http://ir.valeant.com/investor-relations/news-releases/news-release-details/2008/Valeant-to-Acquire-Dow-Pharmaceutical-Sciences-Inc-for-285-Million/default.aspx|title=Valeant - Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million|publisher=Ir.valeant.com|accessdate=7 October 2014}}&lt;/ref&gt;</div></td>
</tr>
<tr>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"></td>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"></td>
</tr>
<tr>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"><div>'''2009'''</div></td>
  <td class="diff-marker">&#160;</td>
  <td class="diff-context"><div>'''2009'''</div></td>
</tr>
</table><hr class='diff-hr' id='mw-oldid' />
		<h2 class='diff-currentversion-title'>Revision as of 22:09, 21 October 2014</h2>
<table class="infobox vcard" style="width:22em">
<caption class="fn org">Valeant Pharmaceuticals International, Inc.</caption>
<tr>
<td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Valeant_logo.svg" class="image" title="Valeant Pharmaceuticals International"><img alt="Valeant Pharmaceuticals International" src="//upload.wikimedia.org/wikipedia/en/thumb/e/e3/Valeant_logo.svg/248px-Valeant_logo.svg.png" width="248" height="38" srcset="//upload.wikimedia.org/wikipedia/en/thumb/e/e3/Valeant_logo.svg/372px-Valeant_logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/e/e3/Valeant_logo.svg/496px-Valeant_logo.svg.png 2x" data-file-width="1024" data-file-height="156" /></a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">
<div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Types_of_business_entity" title="Types of business entity">Type</a></div>
</th>
<td class="category" style="line-height:1.35em;"><a href="/wiki/Public_company" title="Public company">Public company</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded&#160;as</a></th>
<td style="line-height:1.35em;"><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>:&#160;<a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:VRX">VRX</a><br />
<a href="/wiki/Toronto_Stock_Exchange" title="Toronto Stock Exchange">TSX</a>:&#160;<a rel="nofollow" class="external text" href="http://web.tmxmoney.com/quote.php?qm_symbol=VRX:TSX">VRX</a><br />
<a href="/wiki/S%26P/TSX_60" title="S&amp;P/TSX 60">S&amp;P/TSX 60 component</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">Industry</th>
<td class="category" style="line-height:1.35em;"><a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceutical industry</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">Founded</th>
<td style="line-height:1.35em;">1960</td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">Headquarters</th>
<td class="label" style="line-height:1.35em;"><a href="/wiki/Laval,_Quebec" title="Laval, Quebec">Laval</a>, <a href="/wiki/Quebec" title="Quebec">Quebec</a>, <a href="/wiki/Canada" title="Canada">Canada</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">
<div style="padding:0.1em 0;line-height:1.2em;">Key people</div>
</th>
<td class="agent" style="line-height:1.35em;"><a href="/wiki/J._Michael_Pearson" title="J. Michael Pearson">J. Michael Pearson</a> <small>(<a href="/wiki/Chairman" title="Chairman">Chairman</a> &amp; <a href="/wiki/CEO" title="CEO" class="mw-redirect">CEO</a>)</small></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">Products</th>
<td style="line-height:1.35em;"><a href="/wiki/Cesamet" title="Cesamet" class="mw-redirect">Cesamet</a> (<a href="/wiki/Nabilone" title="Nabilone">nabilone</a>)<br />
<a href="/wiki/Efudex" title="Efudex" class="mw-redirect">Efudex</a><br />
<a href="/wiki/Mestinon" title="Mestinon" class="mw-redirect">Mestinon</a><br />
<a href="/wiki/Diastat" title="Diastat" class="mw-redirect">Diastat</a><br />
<a href="/wiki/Ribavirin" title="Ribavirin">Ribavirin</a> (licensed to <a href="/wiki/Schering-Plough" title="Schering-Plough">Schering Plough</a>)</td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">Revenue</th>
<td style="line-height:1.35em;">$3.5 billion (2012)<sup id="cite_ref-agrees_1-0" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th scope="row" style="text-align:left;padding-right:0.5em;">Website</th>
<td style="line-height:1.35em;"><a rel="nofollow" class="external text" href="http://www.valeant.com">www.valeant.com</a></td>
</tr>
</table>
<p><b>Valeant Pharmaceuticals International, Inc.</b> is a publicly traded <a href="/wiki/Pharmaceutical" title="Pharmaceutical" class="mw-redirect">pharmaceutical</a> company based in <a href="/wiki/Montreal" title="Montreal">Montreal</a>, Canada.<sup id="cite_ref-eyes_2-0" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup> The focus of the company is on <a href="/wiki/Neurology" title="Neurology">neurology</a>, <a href="/wiki/Dermatology" title="Dermatology">dermatology</a> and <a href="/wiki/Infectious_disease" title="Infectious disease" class="mw-redirect">infectious disease</a> with several drugs in late-stage clinical trials and several currently on the market. In addition, Valeant has a portfolio of more than 500 products from its prior history as a group of specialty chemical and radiochemical research, development and supply companies with a history stretching back to the 1960s.</p>
<p>Valeant sells a wide range of drugs, including over-the counter medications and medical devices, as well as prescription drugs such as <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> <a href="/wiki/Wellbutrin" title="Wellbutrin" class="mw-redirect">Wellbutrin</a> XL.<sup id="cite_ref-agrees_1-1" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> Kinerase, which uses <a href="/wiki/Kinetin" title="Kinetin">kinetin</a> as active ingredient, is one of the most popular products of Valeant.</p>
<p>An important part of the growth strategy for Valeant has been acquisitions, sometimes in the multi-billion dollar range, of medical and pharmaceutical companies.<sup id="cite_ref-agrees_1-2" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> As of May 2013, the company was valued at $29.2 billion, making it the 17th largest public company in Canada. It is the largest pharmaceutical company in Canada.<sup id="cite_ref-eyes_2-1" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Mergers_and_acquisitions"><span class="tocnumber">2</span> <span class="toctext">Mergers and acquisitions</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Attempted_acquisition_of_Allergan"><span class="tocnumber">2.1</span> <span class="toctext">Attempted acquisition of Allergan</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#References"><span class="tocnumber">3</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="History">History</span></h2>
<p>Valeant was founded as a United States business.<sup id="cite_ref-agrees_1-3" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> It has undergone major management, operational and strategic restructurings since the 1990s when shareholders of several group units approved the merger of ICN Pharmaceuticals (founded by <a href="/wiki/Milan_Pani%C4%87" title="Milan Panić">Milan Panić</a>), ICN Biomedicals, SPI Pharmaceuticals and Viratek into a new global entity, ICN Pharmaceuticals, the immediate forebear of Valeant.</p>
<p>In 2008 the Swedish pharmaceutical company <a href="/wiki/Meda_AB" title="Meda AB">Meda AB</a> bought branches in Western and Eastern Europe from Valeant Pharmaceuticals for $392 Million.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mergers_and_acquisitions">Mergers and acquisitions</span></h2>
<p><b>2008</b></p>
<p>In September, Valeant acquired <a href="/w/index.php?title=Coria_Laboratories,_Ltd&amp;action=edit&amp;redlink=1" class="new" title="Coria Laboratories, Ltd (page does not exist)">Coria Laboratories, Ltd</a> for $95 million, acquiring the outstanding shares from Corias parent company <a href="/w/index.php?title=DFB_Pharmaceuticals,_Inc.&amp;action=edit&amp;redlink=1" class="new" title="DFB Pharmaceuticals, Inc. (page does not exist)">DFB Pharmaceuticals, Inc.</a><sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> In November, Valeant acquired <a href="/w/index.php?title=DermaTech&amp;action=edit&amp;redlink=1" class="new" title="DermaTech (page does not exist)">DermaTech</a> for about $12.6 million.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> In December Valeant announced their acquisition of <a href="/w/index.php?title=Dow_Pharmaceutical_Sciences,_Inc&amp;action=edit&amp;redlink=1" class="new" title="Dow Pharmaceutical Sciences, Inc (page does not exist)">Dow Pharmaceutical Sciences, Inc</a> for $285 million.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup></p>
<p><b>2009</b></p>
<p>In July, Valeant announced its acquisition of <a href="/w/index.php?title=Tecnofarma&amp;action=edit&amp;redlink=1" class="new" title="Tecnofarma (page does not exist)">Tecnofarma</a>, a Mexican generic company.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> In December Valeant announced its Canadian subsidiary would acquire the cosmeceutical Canadian company, <a href="/w/index.php?title=Laboratoire_Dr._Renaud&amp;action=edit&amp;redlink=1" class="new" title="Laboratoire Dr. Renaud (page does not exist)">Laboratoire Dr. Renaud</a>, for C$23 million.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup></p>
<p><b>2010</b></p>
<p>In March, Valeant announced its aqusition of a Brazilian generics and over the counter company for $28 million and manufacutirng plant for a further $28 million.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup></p>
<p>In April Valeant announced that its Canadian subsidiary would acquire <a href="/w/index.php?title=Vital_Science_Corp.&amp;action=edit&amp;redlink=1" class="new" title="Vital Science Corp. (page does not exist)">Vital Science Corp.</a> for C$10.5 million.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> In May 2010, Valeant announced that it was acquiring Aton Pharmaceuticals for about $318 million.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup></p>
<p>On September 28, 2010, Valeant was purchased by <a href="/wiki/Biovail" title="Biovail">Biovail</a>. The new company retained the Valeant name and kept J. Michael Pearson as CEO, but was incorporated in Canada and temporarily kept Biovail's headquarters.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> In May 2011, former Biovail Corporation Chairman and CEO <a href="/wiki/Eugene_Melnyk" title="Eugene Melnyk">Eugene Melnyk</a> was banned from senior roles at public companies in Canada for five years and penalized to pay $565,000 by the <a href="/wiki/Ontario_Securities_Commission" title="Ontario Securities Commission">Ontario Securities Commission</a>. In the year before the merger with Valeant, Melnyk had settled with the <a href="/wiki/United_States_Securities_and_Exchange_Commission" title="United States Securities and Exchange Commission" class="mw-redirect">United States Securities and Exchange Commission</a> (SEC), agreeing to pay a civil penalty of $150,000 US having previously paid $1 million U.S. to settle other claims with the SEC.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<p>Since the 2010 merger, Valeant has aggressively expanded through acquisition. It makes about 25 deals a year, according to CEO Mike Pearson, most of which are too small to require financial reporting.<sup id="cite_ref-agrees_1-4" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> Deals usually focus on specialized high-margin markets such as dermatology and eye care.<sup id="cite_ref-eyes_2-2" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup> A total of 14 purchases were publicly announced from 2010-early 2013.</p>
<p><b>2011</b></p>
<p>In March, an attempt to buy drugmaker <a href="/wiki/Cephalon" title="Cephalon">Cephalon</a> Inc. for $5.7 billion was unsuccessful.<sup id="cite_ref-agrees_1-5" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> but Valeant acquired <a href="/w/index.php?title=PharmaSwiss_S.A.&amp;action=edit&amp;redlink=1" class="new" title="PharmaSwiss S.A. (page does not exist)">PharmaSwiss S.A.</a>.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> In August, Valeant acquired 87.2&#160;% of the outstanding shares of <a href="/w/index.php?title=Sanitas_Group&amp;action=edit&amp;redlink=1" class="new" title="Sanitas Group (page does not exist)">Sanitas Group</a> for EUR314 million.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> In December Valeant acquired <a href="/w/index.php?title=INova&amp;action=edit&amp;redlink=1" class="new" title="INova (page does not exist)">iNova</a> for A$625 million with additional milestone payments of up to A$75 million<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> as well as acquiring <a href="/w/index.php?title=Dermik&amp;action=edit&amp;redlink=1" class="new" title="Dermik (page does not exist)">Dermik</a>, a dermatology unit of <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a><sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup></p>
<p><b>2012</b></p>
<p>In January Valeant acquired Brazilian sports nutrtion company <a href="/w/index.php?title=Probiotica_Laboratorios_Ltda&amp;action=edit&amp;redlink=1" class="new" title="Probiotica Laboratorios Ltda (page does not exist)">Probiotica Laboratorios Ltda</a> for R$150 million.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> In February Valeant acquired ophthalmic biotechnology company, <a href="/w/index.php?title=Eyetech_Inc&amp;action=edit&amp;redlink=1" class="new" title="Eyetech Inc (page does not exist)">Eyetech Inc</a>.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup> In April Valeant acquired <a href="/w/index.php?title=Pedinol&amp;action=edit&amp;redlink=1" class="new" title="Pedinol (page does not exist)">Pedinol</a>.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup> In June Valeant acquired <a href="/wiki/OraPharma" title="OraPharma" class="mw-redirect">OraPharma</a> for approximately $312 million with up to $144 million being paid in milestone payments.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup> In August, Valeant agreed to buy skin-care company <a href="/wiki/Medicis_Pharmaceutical" title="Medicis Pharmaceutical">Medicis Pharmaceutical</a> for $2.6 billion. The price, $44/share in cash, represented a 39% premium on Medicis' stock.<sup id="cite_ref-Medicis_22-0" class="reference"><a href="#cite_note-Medicis-22"><span>[</span>22<span>]</span></a></sup> Valeant projected annual R&amp;D and overhead cost cutting of $225 million from the deal. An analyst for <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i> said "the deal ticks all the right boxes for Valeant share holders."<sup id="cite_ref-Medicis_22-1" class="reference"><a href="#cite_note-Medicis-22"><span>[</span>22<span>]</span></a></sup> The deal was the largest of the 14 announced mergers.<sup id="cite_ref-agrees_1-6" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup></p>
<p><b>2013</b></p>
<p>In January, Valeant acquired the <a href="/wiki/Russia" title="Russia">Russian</a> company <a href="/w/index.php?title=Natur_Produkt&amp;action=edit&amp;redlink=1" class="new" title="Natur Produkt (page does not exist)">Natur Produkt</a> for $163 million.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup> In March, Valeant acquired <a href="/w/index.php?title=Obagi_Medical_Products,_Inc.&amp;action=edit&amp;redlink=1" class="new" title="Obagi Medical Products, Inc. (page does not exist)">Obagi Medical Products, Inc.</a> for $19.75 per share.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> In May, Valeant agreed to buy <a href="/wiki/Bausch_%26_Lomb" title="Bausch &amp; Lomb">Bausch &amp; Lomb</a>, a maker of contact lens solution and surgical devices, from <a href="/wiki/Warburg_Pincus" title="Warburg Pincus">Warburg Pincus</a> LLC for <a href="/wiki/US$" title="US$" class="mw-redirect">US$</a>8.57 billion in cash.<sup id="cite_ref-agrees_1-7" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> The deal, which was approved by shareholder, includes $4.2 billion earmarked to pay down Bausch &amp; Lomb debt.<sup id="cite_ref-eyes_2-3" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup> It is Valeant's largest acquisition to date and will be financed by with $1.5-$2 billion of new equity, and $6–7 billion of new debt.<sup id="cite_ref-agrees_1-8" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> The new debt will bring the company's total to approximately $18 billion. Analyst Neil Maruoka called the purchase an "excellent fit" for Valeant.<sup id="cite_ref-eyes_2-4" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup> The company's stock rose about 25% when the deal was announced.<sup id="cite_ref-eyes_2-5" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Valeant's existing eye care businesses will be moved to the Bausch &amp; Lomb headquarters in <a href="/wiki/Rochester,_New_York" title="Rochester, New York">Rochester, New York</a>.<sup id="cite_ref-agrees_1-9" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> The company expects to achieve at least $800 million annually in cost savings, mostly from reduced R&amp;D and overhead, as a result.<sup id="cite_ref-eyes_2-6" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup> The acquisition will help Valeant enter markets such as China that it previously did not compete in.<sup id="cite_ref-agrees_1-10" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> Valeant will employ roughly 18,000 people after the deal is complete, which is expected to occur in the third quarter of 2013.<sup id="cite_ref-agrees_1-11" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-eyes_2-7" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup>Bausch &amp; Lomb was founded in 1853 acquired by Warburg Pincus in 2007 in a <a href="/wiki/Leveraged_buyout" title="Leveraged buyout">leveraged buyout</a>.<sup id="cite_ref-agrees_1-12" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-eyes_2-8" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup> Warburg Pincus had previous attempted to sell Bausch &amp; Lomb for $10 billion. Bausch &amp; Lomb had filled for an <a href="/wiki/Initial_public_offering" title="Initial public offering">initial public offering</a> after failing to find a buyer. The company had $3 billion of sales in 2012.<sup id="cite_ref-agrees_1-13" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Valeant CEO Mike Pearson said the company would continue to pursue mergers and acquisitions in the near future, but would need three or four month to get a handle on Bausch &amp; Lomb before deciding on its next target. "We certainly continue to explore, continue to have discussions and we hope [mergers of equals] will eventually be part of the playbook", Pearson told investors in a conference call.<sup id="cite_ref-agrees_1-14" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> He added that the company would "never fall in love with any of our assets" and would sell an asset to the right buyer.<sup id="cite_ref-agrees_1-15" class="reference"><a href="#cite_note-agrees-1"><span>[</span>1<span>]</span></a></sup> Maruoka said one of Valeant's core strengths is its ability to integrate large acquisitions with its existing businesses.<sup id="cite_ref-eyes_2-9" class="reference"><a href="#cite_note-eyes-2"><span>[</span>2<span>]</span></a></sup></p>
<p><b>2014</b></p>
<p>In January Valeant acquired <a href="/w/index.php?title=Solta_Medical,_Inc.&amp;action=edit&amp;redlink=1" class="new" title="Solta Medical, Inc. (page does not exist)">Solta Medical, Inc.</a> for approximately $250 million.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> In February, Valeant would acquire <a href="/w/index.php?title=PreCision_Dermatology&amp;action=edit&amp;redlink=1" class="new" title="PreCision Dermatology (page does not exist)">PreCision Dermatology</a> Inc for $475 million, a deal aimed at strengthening the firm’s skin products business.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup> In May, it was announced that <a href="/wiki/Nestle" title="Nestle" class="mw-redirect">Nestle</a> would acquire the commercial rights to sell Valeants filler and toxin products for $1.4 billion.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Attempted_acquisition_of_Allergan">Attempted acquisition of Allergan</span></h3>
<p>On April 22, 2014, details were released by Valeant and hedgefund CEO, <a href="/wiki/Bill_Ackman" title="Bill Ackman">Bill Ackman</a>, about a $46 billion (CAD) offer presented to <a href="/wiki/Allergan" title="Allergan">Allergan</a>.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> Valeant is proposing to exchange $48.30 in cash and 0.83 shares of Valeant per Allergan share. Allergan Inc. stockholders would own 43 per cent of the combined company. This bid was rejected by Allergan as being too risky, claiming Valeant's business model of serial acquisitions and low organic growth being unsustainable. Soon after Valeant released a statement saying a new offer will be presented May 28, 2014, where it emerged that Valeant had increased their offer to $49.4 billion.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup> On May 31 the offer was revised and increased to $53.3 billion.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> On June 18, Valeant began its tender offer for a hostile takover of Allergan.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> In August 27 2014, Valeant and Pershing Square Capital Management asked a Chancery Judge to set a trial for September 24 2014 to decide on whether Valeant and Pershing had properly secured enough support from Allergan shareholders to force a meeting of investors to consider replacing a majority of the company’s directors.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> On the same day Allergan announced that they had set a December shareholder vote to decide whether the company should replace part of the board of directors.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> In the afternoon of August 27, <i>Bloomberg</i> reported that Valeant and Pershing Square had won their case with the Chancery Judge setting an October 6 date for the aforementioned trial.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span></h2>
<div class="reflist references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-agrees-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-agrees_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-agrees_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-agrees_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-agrees_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-agrees_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-agrees_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-agrees_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-agrees_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-agrees_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-agrees_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-agrees_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-agrees_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-agrees_1-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-agrees_1-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-agrees_1-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-agrees_1-15"><sup><i><b>p</b></i></sup></a></span> <span class="reference-text"><span class="citation news">Alex Wayne (May 28, 2013). <a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2013-05-27/valeant-agrees-to-buy-bausch-lomb-for-4-5-billion-cash.html">"Valeant Agrees to Buy Bausch &amp; Lomb in $8.7 Billion Deal"</a>. <i>Bloomberg</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Valeant+Agrees+to+Buy+Bausch+%26+Lomb+in+%248.7+Billion+Deal&amp;rft.au=Alex+Wayne&amp;rft.aulast=Alex+Wayne&amp;rft.date=May+28%2C+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2013-05-27%2Fvaleant-agrees-to-buy-bausch-lomb-for-4-5-billion-cash.html&amp;rft.jtitle=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-eyes-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-eyes_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-eyes_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-eyes_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-eyes_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-eyes_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-eyes_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-eyes_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-eyes_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-eyes_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-eyes_2-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation news">Richard Blackwell; Sean Silcoff; Bertrand Marotte (May 27, 2013). <a rel="nofollow" class="external text" href="http://www.theglobeandmail.com/report-on-business/valeant-to-buy-bausch-lomb-for-87-billion/article12163939/">"Valeant Pharmaceuticals eyes China with Bausch deal"</a>. <i>The Global and Mail</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 29,</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Valeant+Pharmaceuticals+eyes+China+with+Bausch+deal&amp;rft.au=Bertrand+Marotte&amp;rft.aulast=Richard+Blackwell&amp;rft.au=Richard+Blackwell&amp;rft.au=Sean+Silcoff&amp;rft.date=May+27%2C+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.theglobeandmail.com%2Freport-on-business%2Fvaleant-to-buy-bausch-lomb-for-87-billion%2Farticle12163939%2F&amp;rft.jtitle=The+Global+and+Mail&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.biospace.com/news_story.aspx?NewsEntityId=105546">"Swedens Meda AB Buys American Valeant Pharmaceuticals International Units for 392 Million"</a>. Biodpace.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Swedens+Meda+AB+Buys+American+Valeant+Pharmaceuticals+International+Units+for+392+Million&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.biospace.com%2Fnews_story.aspx%3FNewsEntityId%3D105546&amp;rft.pub=Biodpace.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2008/Valeant-Pharmaceuticals-Signs-Agreement-to-Acquire-Coria-Laboratories-Ltd/default.aspx">"Valeant - Valeant Pharmaceuticals Signs Agreement to Acquire Coria Laboratories, Ltd."</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Signs+Agreement+to+Acquire+Coria+Laboratories%2C+Ltd.&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2008%2FValeant-Pharmaceuticals-Signs-Agreement-to-Acquire-Coria-Laboratories-Ltd%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/valeant-pharmaceuticals-acquires-dermatech-for-12-6m/45513163/?kwrd=valeant%20acquires">"GEN - News Highlights: Valeant Pharmaceuticals Acquires DermaTech for $12.6M"</a>. <i>GEN</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=GEN+-+News+Highlights%3A+Valeant+Pharmaceuticals+Acquires+DermaTech+for+%2412.6M&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fvaleant-pharmaceuticals-acquires-dermatech-for-12-6m%2F45513163%2F%3Fkwrd%3Dvaleant%2520acquires&amp;rft.jtitle=GEN&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2008/Valeant-to-Acquire-Dow-Pharmaceutical-Sciences-Inc-for-285-Million/default.aspx">"Valeant - Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+to+Acquire+Dow+Pharmaceutical+Sciences%2C+Inc.+for+%24285+Million&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2008%2FValeant-to-Acquire-Dow-Pharmaceutical-Sciences-Inc-for-285-Million%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2009/Valeant-to-Acquire-Tecnofarma-A-Mexican-Generic-Company/default.aspx">"Valeant - Valeant to Acquire Tecnofarma, A Mexican Generic Company"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+to+Acquire+Tecnofarma%2C+A+Mexican+Generic+Company&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2009%2FValeant-to-Acquire-Tecnofarma-A-Mexican-Generic-Company%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2009/Valeant-to-Acquire-Laboratoire-Dr-Renaud-in-Canada/default.aspx">"Valeant - Valeant to Acquire Laboratoire Dr. Renaud in Canada"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+to+Acquire+Laboratoire+Dr.+Renaud+in+Canada&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2009%2FValeant-to-Acquire-Laboratoire-Dr-Renaud-in-Canada%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2010/Valeant-to-Acquire-Branded-GenericsOTC-Company-in-Brazil/default.aspx">"Valeant - Valeant to Acquire Branded Generics/OTC Company in Brazil"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+to+Acquire+Branded+Generics%2FOTC+Company+in+Brazil&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2010%2FValeant-to-Acquire-Branded-GenericsOTC-Company-in-Brazil%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2010/Valeant-to-Acquire-Vital-Science-Corp-in-Canada/default.aspx">"Valeant - Valeant to Acquire Vital Science Corp. in Canada"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+to+Acquire+Vital+Science+Corp.+in+Canada&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2010%2FValeant-to-Acquire-Vital-Science-Corp-in-Canada%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.reuters.com/article/idCNSGE6420HF20100503?rpc=44">"UPDATE 1-Valeant Q1 profit beats Street; to acquire Aton Pharma"</a>. <i>Reuters</i>. May 3, 2010.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=UPDATE+1-Valeant+Q1+profit+beats+Street%3B+to+acquire+Aton+Pharma&amp;rft.date=May+3%2C+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidCNSGE6420HF20100503%3Frpc%3D44&amp;rft.jtitle=Reuters&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.reuters.com/article/2010/06/21/us-biovail-valeant-idUSTRE65K1LA20100621">"Drugmaker Biovail to buy Valeant in $3.3 billion deal"</a>. <i>Reuters</i>. June 21, 2010.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Drugmaker+Biovail+to+buy+Valeant+in+%243.3+billion+deal&amp;rft.date=June+21%2C+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2F2010%2F06%2F21%2Fus-biovail-valeant-idUSTRE65K1LA20100621&amp;rft.jtitle=Reuters&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.ottawacitizen.com/business/Senators+owner+Melnyk+banned+five+years+from+boardrooms+public+companies/4733378/story.html">"Senators owner Melnyk banned for five years from boardrooms of public companies The Financial Post by Barbara Shector, May 5, 2011"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-05-05</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Senators+owner+Melnyk+banned+for+five+years+from+boardrooms+of+public+companies+The+Financial+Post+by+Barbara+Shector%2C+May+5%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.ottawacitizen.com%2Fbusiness%2FSenators%2Bowner%2BMelnyk%2Bbanned%2Bfive%2Byears%2Bfrom%2Bboardrooms%2Bpublic%2Bcompanies%2F4733378%2Fstory.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2011/Valeant-Pharmaceuticals-Completes-Acquisition-of-PharmaSwiss-SA/default.aspx">"Valeant - Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A."</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Completes+Acquisition+of+PharmaSwiss+S.A.&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2011%2FValeant-Pharmaceuticals-Completes-Acquisition-of-PharmaSwiss-SA%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2011/Valeant-Pharmaceuticals-Agrees-to-Acquire-Sanitas-Group-for-Approximately-EUR314-Million-in-Cash/default.aspx">"Valeant - Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Agrees+to+Acquire+Sanitas+Group+for+Approximately+EUR314+Million+in+Cash&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2011%2FValeant-Pharmaceuticals-Agrees-to-Acquire-Sanitas-Group-for-Approximately-EUR314-Million-in-Cash%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2011/Valeant-Pharmaceuticals-Agrees-to-Acquire-iNova/default.aspx">"Valeant - Valeant Pharmaceuticals Agrees to Acquire iNova"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Agrees+to+Acquire+iNova&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2011%2FValeant-Pharmaceuticals-Agrees-to-Acquire-iNova%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2011/Valeant-Pharmaceuticals-Completes-Acquisition-of-Dermik/default.aspx">"Valeant - Valeant Pharmaceuticals Completes Acquisition of Dermik"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Completes+Acquisition+of+Dermik&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2011%2FValeant-Pharmaceuticals-Completes-Acquisition-of-Dermik%2Fdefault.aspx&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2012/Valeant-Pharmaceuticals-Acquires-Probiotica-in-Brazil/default.aspx">"Valeant - Valeant Pharmaceuticals Acquires Probiotica in Brazil"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Acquires+Probiotica+in+Brazil&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2012%2FValeant-Pharmaceuticals-Acquires-Probiotica-in-Brazil%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2012/Valeant-Pharmaceuticals-to-Acquire-Eyetech/default.aspx">"Valeant - Valeant Pharmaceuticals to Acquire Eyetech"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+to+Acquire+Eyetech&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2012%2FValeant-Pharmaceuticals-to-Acquire-Eyetech%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2012/Valeant-Pharmaceuticals-to-Acquire-Pedinol/default.aspx">"Valeant - Valeant Pharmaceuticals to Acquire Pedinol"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+to+Acquire+Pedinol&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2012%2FValeant-Pharmaceuticals-to-Acquire-Pedinol%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2012/Valeant-Pharmaceuticals-Agrees-To-Acquire-OraPharma1130688/default.aspx">"Valeant - Valeant Pharmaceuticals Agrees To Acquire OraPharma"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+Agrees+To+Acquire+OraPharma&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2012%2FValeant-Pharmaceuticals-Agrees-To-Acquire-OraPharma1130688%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Medicis-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Medicis_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Medicis_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.forbes.com/sites/davidmaris/2012/09/03/valeant-to-acquire-medicis-for-2-6-billion/">"Valeant To Acquire Medicis for $2.6 Billion"</a>. <i>Forbes</i>. September 3, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">June 2,</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Valeant+To+Acquire+Medicis+for+%242.6+Billion&amp;rft.date=September+3%2C+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidmaris%2F2012%2F09%2F03%2Fvaleant-to-acquire-medicis-for-2-6-billion%2F&amp;rft.jtitle=Forbes&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2013/Valeant-Completes-Acquisition-Of-Natur-Produkt-In-Russia1133347/default.aspx">"Valeant - Valeant Completes Acquisition Of Natur Produkt In Russia"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Completes+Acquisition+Of+Natur+Produkt+In+Russia&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2013%2FValeant-Completes-Acquisition-Of-Natur-Produkt-In-Russia1133347%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2013/Valeant-Pharmaceuticals-International-Inc-Agrees-to-Acquire-Obagi-Medical-Products-Inc-for-1975-Per-Share-in-Cash/default.aspx">"Valeant - Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash"</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+International%2C+Inc.+Agrees+to+Acquire+Obagi+Medical+Products%2C+Inc.+for+%2419.75+Per+Share+in+Cash&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2013%2FValeant-Pharmaceuticals-International-Inc-Agrees-to-Acquire-Obagi-Medical-Products-Inc-for-1975-Per-Share-in-Cash%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ir.valeant.com/investor-relations/news-releases/news-release-details/2014/Valeant-Pharmaceuticals-International-Inc-Completes-Acquisition-Of-Solta-Medical-Inc/default.aspx">"Valeant - Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta Medical, Inc."</a>. Ir.valeant.com<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+-+Valeant+Pharmaceuticals+International%2C+Inc.+Completes+Acquisition+Of+Solta+Medical%2C+Inc.&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fir.valeant.com%2Finvestor-relations%2Fnews-releases%2Fnews-release-details%2F2014%2FValeant-Pharmaceuticals-International-Inc-Completes-Acquisition-Of-Solta-Medical-Inc%2Fdefault.aspx&amp;rft.pub=Ir.valeant.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation web">Euan Rocha (4 February 2014). <a rel="nofollow" class="external text" href="http://www.reuters.com/article/2014/02/03/us-valeantpharmaceuticals-acquisition-idUSBREA120S320140203">"Valeant to buy PreCision Dermatology for $475 million"</a>. Reuters.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.au=Euan+Rocha&amp;rft.aulast=Euan+Rocha&amp;rft.btitle=Valeant+to+buy+PreCision+Dermatology+for+%24475+million&amp;rft.date=4+February+2014&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F02%2F03%2Fus-valeantpharmaceuticals-acquisition-idUSBREA120S320140203&amp;rft.pub=Reuters&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-05-28/nestle-to-buy-skin-care-rights-from-valeant-for-1-4-billion.html">"Nestle acquires rights toValeant skincare products"</a>. Bloomberg<span class="reference-accessdate">. Retrieved <span class="nowrap">29 May</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Nestle+acquires+rights+toValeant+skincare+products&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-05-28%2Fnestle-to-buy-skin-care-rights-from-valeant-for-1-4-billion.html&amp;rft.pub=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cbc.ca/news/business/valeant-bill-ackman-bid-45b-for-botox-maker-allergan-1.2617495">"Valeant, Bill Ackman bid $45B for Botox-maker Allergan"</a>. Canadian Associated Press / CBC<span class="reference-accessdate">. Retrieved <span class="nowrap">22 April</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant%2C+Bill+Ackman+bid+%2445B+for+Botox-maker+Allergan&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cbc.ca%2Fnews%2Fbusiness%2Fvaleant-bill-ackman-bid-45b-for-botox-maker-allergan-1.2617495&amp;rft.pub=Canadian+Associated+Press+%2F+CBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-05-28/valeant-raises-takeover-offer-for-allergan-with-more-cash.html">"Valeant raises offer for Allergan"</a>. Bloomberg<span class="reference-accessdate">. Retrieved <span class="nowrap">29 May</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+raises+offer+for+Allergan&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-05-28%2Fvaleant-raises-takeover-offer-for-allergan-with-more-cash.html&amp;rft.pub=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-05-30/valeant-raises-takeover-offer-for-allergan-for-second-time.html">"Valeant raises offer for Allergan for second time"</a>. Bloomberg<span class="reference-accessdate">. Retrieved <span class="nowrap">31 May</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.btitle=Valeant+raises+offer+for+Allergan+for+second+time&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-05-30%2Fvaleant-raises-takeover-offer-for-allergan-for-second-time.html&amp;rft.pub=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-06-18/valeant-begins-tender-offer-for-allergan-hostile-takeover.html">"Valeant Begins Tender Offer for Allergan Hostile Takeover"</a>. <i>Bloomberg</i>. 18 June 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Valeant+Begins+Tender+Offer+for+Allergan+Hostile+Takeover&amp;rft.date=18+June+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-06-18%2Fvaleant-begins-tender-offer-for-allergan-hostile-takeover.html&amp;rft.jtitle=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation web">Jef Feeley (27 August 2014). <a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-08-26/allergan-says-valeant-seeking-hearing-on-shareholder-meeting-1-.html">"Allergan Says Valeant Seeking Hearing on Shareholder Meeting"</a>. <i>Bloomberg</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Allergan+Says+Valeant+Seeking+Hearing+on+Shareholder+Meeting&amp;rft.au=Jef+Feeley&amp;rft.aulast=Jef+Feeley&amp;rft.date=27+August+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-08-26%2Fallergan-says-valeant-seeking-hearing-on-shareholder-meeting-1-.html&amp;rft.jtitle=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-08-26/allergan-sets-december-shareholder-vote-on-valeant-bid.html">"Allergan Sets December Shareholder Vote on Valeant Bid"</a>. <i>Bloomberg</i>. 27 August 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Allergan+Sets+December+Shareholder+Vote+on+Valeant+Bid&amp;rft.date=27+August+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-08-26%2Fallergan-sets-december-shareholder-vote-on-valeant-bid.html&amp;rft.jtitle=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation web">Jef Feeley (27 August 2014). <a rel="nofollow" class="external text" href="http://www.bloomberg.com/news/2014-08-27/valeant-ackman-win-bid-to-fast-track-allergan-case.html">"Valeant, Ackman Win Bid to Fast-Track Allergan Case"</a>. <i>Bloomberg</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AValeant+Pharmaceuticals&amp;rft.atitle=Valeant%2C+Ackman+Win+Bid+to+Fast-Track+Allergan+Case&amp;rft.au=Jef+Feeley&amp;rft.aulast=Jef+Feeley&amp;rft.date=27+August+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-08-27%2Fvaleant-ackman-win-bid-to-fast-track-allergan-case.html&amp;rft.jtitle=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Pharmaceutical_companies_of_the_United_States" title="Template:Pharmaceutical companies of the United States"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Pharmaceutical_companies_of_the_United_States" title="Template talk:Pharmaceutical companies of the United States"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Pharmaceutical_companies_of_the_United_States&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Category:Pharmaceutical_companies_of_the_United_States" title="Category:Pharmaceutical companies of the United States">Pharmaceutical companies of the United States</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Abbott_Laboratories" title="Abbott Laboratories">Abbott Laboratories</a></li>
<li><a href="/wiki/Acorda_Therapeutics" title="Acorda Therapeutics">Acorda Therapeutics</a></li>
<li><a href="/wiki/Actavis" title="Actavis">Actavis</a></li>
<li><a href="/wiki/Aderis_Pharmaceuticals" title="Aderis Pharmaceuticals">Aderis Pharmaceuticals</a></li>
<li><a href="/wiki/Adolor_Corporation" title="Adolor Corporation" class="mw-redirect">Adolor Corporation</a></li>
<li><a href="/wiki/Alcon" title="Alcon">Alcon</a></li>
<li><a href="/wiki/Alexion_Pharmaceuticals" title="Alexion Pharmaceuticals">Alexion Pharmaceuticals</a></li>
<li><a href="/wiki/Alkermes_(company)" title="Alkermes (company)">Alkermes</a></li>
<li><a href="/wiki/Allergan" title="Allergan">Allergan</a></li>
<li><a href="/wiki/Alza" title="Alza">Alza</a></li>
<li><a href="/wiki/Amgen" title="Amgen">Amgen</a></li>
<li><a href="/wiki/Amylin_Pharmaceuticals" title="Amylin Pharmaceuticals">Amylin Pharmaceuticals</a></li>
<li><a href="/wiki/ARIAD_Pharmaceuticals" title="ARIAD Pharmaceuticals">ARIAD Pharmaceuticals</a></li>
<li><a href="/wiki/ARYx_Therapeutics" title="ARYx Therapeutics">ARYx Therapeutics</a></li>
<li><a href="/wiki/Avax_Technologies" title="Avax Technologies">Avax Technologies</a></li>
<li><a href="/wiki/Baxter_International" title="Baxter International">Baxter International</a></li>
<li><a href="/wiki/BioCryst_Pharmaceuticals" title="BioCryst Pharmaceuticals">BioCryst Pharmaceuticals</a></li>
<li><a href="/wiki/Biogen_Idec" title="Biogen Idec">Biogen Idec</a></li>
<li><a href="/wiki/Biolex" title="Biolex">Biolex</a></li>
<li><a href="/wiki/Biovest" title="Biovest">Biovest</a></li>
<li><a href="/wiki/Biovista" title="Biovista">Biovista</a></li>
<li><a href="/wiki/Bradley_Pharmaceuticals" title="Bradley Pharmaceuticals">Bradley Pharmaceuticals</a></li>
<li><a href="/wiki/Bristol-Myers_Squibb" title="Bristol-Myers Squibb">Bristol-Myers Squibb</a></li>
<li><a href="/wiki/CancerVax" title="CancerVax">CancerVax</a></li>
<li><a href="/wiki/Century_Pharmaceuticals" title="Century Pharmaceuticals">Century Pharmaceuticals</a></li>
<li><a href="/wiki/Cephalon" title="Cephalon">Cephalon</a></li>
<li><a href="/wiki/Ceragenix_Pharmaceuticals" title="Ceragenix Pharmaceuticals">Ceragenix Pharmaceuticals</a></li>
<li><a href="/wiki/Combe_Incorporated" title="Combe Incorporated">Combe Incorporated</a></li>
<li><a href="/wiki/Cortex_Pharmaceuticals" title="Cortex Pharmaceuticals">Cortex Pharmaceuticals</a></li>
<li><a href="/wiki/CoTherix" title="CoTherix">CoTherix</a></li>
<li><a href="/wiki/Covance" title="Covance">Covance</a></li>
<li><a href="/wiki/Covidien" title="Covidien">Covidien</a></li>
<li><a href="/wiki/Cubist_Pharmaceuticals" title="Cubist Pharmaceuticals">Cubist Pharmaceuticals</a></li>
<li><a href="/wiki/Cutter_Laboratories" title="Cutter Laboratories">Cutter Laboratories</a></li>
<li><a href="/wiki/CytoSport" title="CytoSport">CytoSport</a></li>
<li><a href="/wiki/CytRx" title="CytRx">CytRx</a></li>
<li><a href="/wiki/Danco_Laboratories" title="Danco Laboratories">Danco Laboratories</a></li>
<li><a href="/wiki/DNAPrint_Genomics" title="DNAPrint Genomics">DNAPrint Genomics</a></li>
<li><a href="/wiki/Epix_Pharmaceuticals" title="Epix Pharmaceuticals">Epix Pharmaceuticals</a></li>
<li><a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a></li>
<li><a href="/wiki/Elorac" title="Elorac">Elorac</a></li>
<li><a href="/wiki/Endo_Pharmaceuticals" title="Endo Pharmaceuticals" class="mw-redirect">Endo Pharmaceuticals</a></li>
<li><a href="/wiki/Ethicon_Endo-Surgery" title="Ethicon Endo-Surgery">Ethicon Endo-Surgery</a></li>
<li><a href="/wiki/Ethicon_Inc." title="Ethicon Inc.">Ethicon Inc.</a></li>
<li><a href="/wiki/Forest_Laboratories" title="Forest Laboratories">Forest Laboratories</a></li>
<li><a href="/wiki/Galena_Biopharma" title="Galena Biopharma">Galena Biopharma</a></li>
<li><a href="/wiki/GenVec" title="GenVec">GenVec</a></li>
<li><a href="/wiki/Genentech" title="Genentech">Genentech</a></li>
<li><a href="/wiki/Genta_(company)" title="Genta (company)">Genta</a></li>
<li><a href="/wiki/Gilead_Sciences" title="Gilead Sciences">Gilead Sciences</a></li>
<li><a href="/wiki/Hospira" title="Hospira">Hospira</a></li>
<li><a href="/wiki/ImClone_Systems" title="ImClone Systems">ImClone Systems</a></li>
<li><a href="/wiki/Institute_for_OneWorld_Health" title="Institute for OneWorld Health">Institute for OneWorld Health</a></li>
<li><a href="/wiki/Intercept_Pharmaceuticals" title="Intercept Pharmaceuticals">Intercept Pharmaceuticals</a></li>
<li><a href="/wiki/ISTA_Pharmaceuticals" title="ISTA Pharmaceuticals">ISTA Pharmaceuticals</a></li>
<li><a href="/wiki/Ivax_Corporation" title="Ivax Corporation">Ivax Corporation</a></li>
<li><a href="/wiki/Janssen_Biotech" title="Janssen Biotech">Janssen Biotech</a></li>
<li><a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a></li>
<li><a href="/wiki/Kinetic_Concepts" title="Kinetic Concepts">Kinetic Concepts</a></li>
<li><a href="/wiki/King_Pharmaceuticals" title="King Pharmaceuticals">King Pharmaceuticals</a></li>
<li><a href="/wiki/Kinray" title="Kinray" class="mw-redirect">Kinray</a></li>
<li><a href="/wiki/KV_Pharmaceutical" title="KV Pharmaceutical">KV Pharmaceutical</a></li>
<li><a href="/wiki/Leiner_Health_Products" title="Leiner Health Products">Leiner Health Products</a></li>
<li><a href="/wiki/Mallinckrodt" title="Mallinckrodt">Mallinckrodt</a></li>
<li><a href="/wiki/Martek_Biosciences_Corporation" title="Martek Biosciences Corporation">Martek Biosciences Corporation</a></li>
<li><a href="/wiki/S._E._Massengill_Company" title="S. E. Massengill Company">S. E. Massengill Company</a></li>
<li><a href="/wiki/McKesson_Corporation" title="McKesson Corporation">McKesson Corporation</a></li>
<li><a href="/wiki/McNeil_Laboratories" title="McNeil Laboratories" class="mw-redirect">McNeil Laboratories</a></li>
<li><a href="/wiki/Melior_Discovery" title="Melior Discovery">Melior Discovery</a></li>
<li><a href="/wiki/Mentholatum" title="Mentholatum">Mentholatum</a></li>
<li><a href="/wiki/Merck_%26_Co." title="Merck &amp; Co.">Merck &amp; Co.</a></li>
<li><a href="/wiki/Miles_Laboratories" title="Miles Laboratories">Miles Laboratories</a></li>
<li><a href="/wiki/Mylan" title="Mylan">Mylan</a></li>
<li><a href="/wiki/Myriad_Genetics" title="Myriad Genetics">Myriad Genetics</a></li>
<li><a href="/wiki/Nereus_Pharmaceuticals" title="Nereus Pharmaceuticals">Nereus Pharmaceuticals</a></li>
<li><a href="/wiki/Northwest_Biotherapeutics" title="Northwest Biotherapeutics">Northwest Biotherapeutics</a></li>
<li><a href="/wiki/Norwich_Pharma_Services" title="Norwich Pharma Services">Norwich Pharma Services</a></li>
<li><a href="/wiki/NovaBay_Pharmaceuticals" title="NovaBay Pharmaceuticals">NovaBay Pharmaceuticals</a></li>
<li><a href="/wiki/Nuvelo" title="Nuvelo">Nuvelo</a></li>
<li><a href="/wiki/Organon_International" title="Organon International">Organon International</a></li>
<li><a href="/wiki/Ortho_Pharmaceutical" title="Ortho Pharmaceutical">Ortho Pharmaceutical</a></li>
<li><a href="/wiki/Ortho-McNeil_Pharmaceutical" title="Ortho-McNeil Pharmaceutical">Ortho-McNeil Pharmaceutical</a></li>
<li><a href="/wiki/OSI_Pharmaceuticals" title="OSI Pharmaceuticals">OSI Pharmaceuticals</a></li>
<li><a href="/wiki/Ovation_Pharmaceuticals" title="Ovation Pharmaceuticals">Ovation Pharmaceuticals</a></li>
<li><a href="/wiki/Par_Pharmaceutical" title="Par Pharmaceutical">Par Pharmaceutical</a></li>
<li><a href="/wiki/Parke-Davis" title="Parke-Davis">Parke-Davis</a></li>
<li><a href="/wiki/Perrigo" title="Perrigo">Perrigo</a></li>
<li><a href="/wiki/Pfizer" title="Pfizer">Pfizer</a></li>
<li><a href="/wiki/Pharmaceutical_Product_Development" title="Pharmaceutical Product Development">Pharmaceutical Product Development</a></li>
<li><a href="/wiki/Prasco_Laboratories" title="Prasco Laboratories">Prasco Laboratories</a></li>
<li><a href="/wiki/Procter_%26_Gamble" title="Procter &amp; Gamble">Procter &amp; Gamble</a></li>
<li><a href="/wiki/Proteon_Therapeutics" title="Proteon Therapeutics">Proteon Therapeutics</a></li>
<li><a href="/wiki/Purdue_Pharma" title="Purdue Pharma">Purdue Pharma</a></li>
<li><a href="/wiki/Qualitest" title="Qualitest">Qualitest</a></li>
<li><a href="/wiki/Quark_Pharmaceuticals" title="Quark Pharmaceuticals">Quark Pharmaceuticals</a></li>
<li><a href="/wiki/Regeneron" title="Regeneron">Regeneron</a></li>
<li><a href="/wiki/Repros_Therapeutics" title="Repros Therapeutics">Repros Therapeutics</a></li>
<li><a href="/wiki/Respa_Pharmaceuticals" title="Respa Pharmaceuticals">Respa Pharmaceuticals</a></li>
<li><a href="/wiki/Rib-X_Pharmaceuticals" title="Rib-X Pharmaceuticals">Rib-X Pharmaceuticals</a></li>
<li><a href="/wiki/Sarepta_Therapeutics" title="Sarepta Therapeutics">Sarepta Therapeutics</a></li>
<li><a href="/wiki/Savage_Laboratories" title="Savage Laboratories">Savage Laboratories</a></li>
<li><a href="/wiki/Schering-Plough" title="Schering-Plough">Schering-Plough</a></li>
<li><a href="/wiki/G._D._Searle_%26_Company" title="G. D. Searle &amp; Company">G. D. Searle &amp; Company</a></li>
<li><a href="/wiki/Sheffield_Pharmaceuticals" title="Sheffield Pharmaceuticals">Sheffield Pharmaceuticals</a></li>
<li><a href="/wiki/Smith,_Kline_%26_French" title="Smith, Kline &amp; French">Smith, Kline &amp; French</a></li>
<li><a href="/wiki/Spectrum_Pharmaceuticals" title="Spectrum Pharmaceuticals">Spectrum Pharmaceuticals</a></li>
<li><a href="/wiki/Sterling_Drug" title="Sterling Drug">Sterling Drug</a></li>
<li><a href="/wiki/Tanox" title="Tanox">Tanox</a></li>
<li><a href="/wiki/TAP_Pharmaceutical_Products" title="TAP Pharmaceutical Products">TAP Pharmaceutical Products</a></li>
<li><a href="/wiki/Tec_Laboratories" title="Tec Laboratories">Tec Laboratories</a></li>
<li><a href="/wiki/Teva_Pharmaceutical_Industries" title="Teva Pharmaceutical Industries">Teva Pharmaceutical Industries</a></li>
<li><a href="/wiki/Tiens_Biotech_Group" title="Tiens Biotech Group">Tiens Biotech Group</a></li>
<li><a href="/wiki/Titan_Pharmaceuticals" title="Titan Pharmaceuticals">Titan Pharmaceuticals</a></li>
<li><a href="/wiki/Trevena_Inc" title="Trevena Inc">Trevena Inc</a></li>
<li><a href="/wiki/Trubion" title="Trubion">Trubion</a></li>
<li><a href="/wiki/Upjohn" title="Upjohn">Upjohn</a></li>
<li><a href="/wiki/Upsher-Smith_Laboratories" title="Upsher-Smith Laboratories">Upsher-Smith Laboratories</a></li>
<li><strong class="selflink">Valeant Pharmaceuticals</strong></li>
<li><a href="/wiki/Ventria_Bioscience" title="Ventria Bioscience">Ventria Bioscience</a></li>
<li><a href="/wiki/Vertex_Pharmaceuticals" title="Vertex Pharmaceuticals">Vertex Pharmaceuticals</a></li>
<li><a href="/wiki/Verus_Pharmaceuticals" title="Verus Pharmaceuticals">Verus Pharmaceuticals</a></li>
<li><a href="/wiki/Vion_Pharmaceuticals,_Inc." title="Vion Pharmaceuticals, Inc.">Vion Pharmaceuticals, Inc.</a></li>
<li><a href="/wiki/ViroPharma" title="ViroPharma">ViroPharma</a></li>
<li><a href="/wiki/Vital_Pharmaceuticals" title="Vital Pharmaceuticals">Vital Pharmaceuticals</a></li>
<li><a href="/wiki/West_Pharmaceutical_Services" title="West Pharmaceutical Services">West Pharmaceutical Services</a></li>
<li><a href="/wiki/Wyeth" title="Wyeth">Wyeth</a></li>
<li><a href="/wiki/Zonite_Products_Corporation" title="Zonite Products Corporation">Zonite Products Corporation</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2">
<div>
<ul>
<li><a href="/wiki/List_of_pharmaceutical_companies" title="List of pharmaceutical companies">List of pharmaceutical companies</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:S%26P/TSX_60" title="Template:S&amp;P/TSX 60"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:S%26P/TSX_60" title="Template talk:S&amp;P/TSX 60"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:S%26P/TSX_60&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/S%26P/TSX_60" title="S&amp;P/TSX 60">S&amp;P/TSX 60</a> companies of <a href="/wiki/Canada" title="Canada">Canada</a> <small>(December 19, 2014)</small></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Agnico_Eagle_Mines_Limited" title="Agnico Eagle Mines Limited">Agnico Eagle Mines</a></li>
<li><a href="/wiki/Agrium" title="Agrium">Agrium</a></li>
<li><a href="/wiki/ARC_Resources" title="ARC Resources">ARC Resources</a></li>
<li><a href="/wiki/Bank_of_Montreal" title="Bank of Montreal">Bank of Montreal</a></li>
<li><a href="/wiki/Scotiabank" title="Scotiabank">Bank of Nova Scotia</a></li>
<li><a href="/wiki/Barrick_Gold" title="Barrick Gold">Barrick Gold</a></li>
<li><a href="/wiki/Bell_Canada" title="Bell Canada">BCE</a></li>
<li><a href="/wiki/BlackBerry_(company)" title="BlackBerry (company)" class="mw-redirect">BlackBerry</a></li>
<li><a href="/wiki/Bombardier_Inc." title="Bombardier Inc.">Bombardier</a></li>
<li><a href="/wiki/Brookfield_Asset_Management" title="Brookfield Asset Management">Brookfield Asset Management</a></li>
<li><a href="/wiki/Cameco" title="Cameco">Cameco</a></li>
<li><a href="/wiki/Canadian_Imperial_Bank_of_Commerce" title="Canadian Imperial Bank of Commerce">Canadian Imperial Bank of Commerce</a></li>
<li><a href="/wiki/Canadian_National_Railway" title="Canadian National Railway">Canadian National</a></li>
<li><a href="/wiki/Canadian_Natural_Resources" title="Canadian Natural Resources">Canadian Natural Resources</a></li>
<li><a href="/wiki/Canadian_Oil_Sands" title="Canadian Oil Sands">Canadian Oil Sands</a></li>
<li><a href="/wiki/Canadian_Pacific_Railway" title="Canadian Pacific Railway">Canadian Pacific</a></li>
<li><a href="/wiki/Canadian_Tire" title="Canadian Tire">Canadian Tire</a></li>
<li><a href="/wiki/Catamaran_Corporation" title="Catamaran Corporation">Catamaran Corporation</a></li>
<li><a href="/wiki/Cenovus_Energy" title="Cenovus Energy">Cenovus Energy</a></li>
<li><a href="/wiki/CGI_Group" title="CGI Group">CGI Group</a></li>
<li><a href="/wiki/Alimentation_Couche-Tard" title="Alimentation Couche-Tard">Couche-Tard</a></li>
<li><a href="/wiki/Crescent_Point_Energy" title="Crescent Point Energy">Crescent Point Energy</a></li>
<li><a href="/wiki/Eldorado_Gold" title="Eldorado Gold">Eldorado Gold</a></li>
<li><a href="/wiki/Enbridge" title="Enbridge">Enbridge</a></li>
<li><a href="/wiki/Encana" title="Encana">Encana</a></li>
<li><a href="/wiki/First_Quantum_Minerals" title="First Quantum Minerals">First Quantum Minerals</a></li>
<li><a href="/wiki/Fortis_Inc." title="Fortis Inc.">Fortis Inc.</a></li>
<li><a href="/wiki/Gildan_Activewear" title="Gildan Activewear">Gildan</a></li>
<li><a href="/wiki/Goldcorp" title="Goldcorp">Goldcorp</a></li>
<li><a href="/wiki/Husky_Energy" title="Husky Energy">Husky Energy</a></li>
<li><a href="/wiki/Imperial_Oil" title="Imperial Oil">Imperial Oil</a></li>
<li><a href="/wiki/Inter_Pipeline" title="Inter Pipeline">Inter Pipeline</a></li>
<li><a href="/wiki/Kinross_Gold" title="Kinross Gold">Kinross Gold</a></li>
<li><a href="/wiki/Loblaw_Companies" title="Loblaw Companies">Loblaw Companies</a></li>
<li><a href="/wiki/Magna_International" title="Magna International">Magna International</a></li>
<li><a href="/wiki/Manulife_Financial" title="Manulife Financial">Manulife Financial</a></li>
<li><a href="/wiki/Metro_Inc." title="Metro Inc.">Metro</a></li>
<li><a href="/wiki/National_Bank_of_Canada" title="National Bank of Canada">National Bank of Canada</a></li>
<li><a href="/wiki/Pembina_Pipeline" title="Pembina Pipeline">Pembina Pipeline</a></li>
<li><a href="/wiki/Potash_Corporation_of_Saskatchewan" title="Potash Corporation of Saskatchewan">PotashCorp</a></li>
<li><a href="/wiki/Power_Corporation_of_Canada" title="Power Corporation of Canada">Power Corporation</a></li>
<li><a href="/wiki/Restaurant_Brands_International" title="Restaurant Brands International">Restaurant Brands International</a></li>
<li><a href="/wiki/Rogers_Communications" title="Rogers Communications">Rogers</a></li>
<li><a href="/wiki/Royal_Bank_of_Canada" title="Royal Bank of Canada">Royal Bank of Canada</a></li>
<li><a href="/wiki/Saputo_Incorporated" title="Saputo Incorporated" class="mw-redirect">Saputo</a></li>
<li><a href="/wiki/Shaw_Communications" title="Shaw Communications">Shaw Communications</a></li>
<li><a href="/wiki/Silver_Wheaton" title="Silver Wheaton">Silver Wheaton</a></li>
<li><a href="/wiki/SNC-Lavalin" title="SNC-Lavalin">SNC-Lavalin</a></li>
<li><a href="/wiki/Sun_Life_Financial" title="Sun Life Financial">Sun Life Financial</a></li>
<li><a href="/wiki/Suncor_Energy" title="Suncor Energy">Suncor Energy</a></li>
<li><a href="/wiki/Talisman_Energy" title="Talisman Energy">Talisman Energy</a></li>
<li><a href="/wiki/Teck_Resources" title="Teck Resources">Teck</a></li>
<li><a href="/wiki/Telus" title="Telus">Telus</a></li>
<li><a href="/wiki/Thomson_Reuters" title="Thomson Reuters">Thomson Reuters</a></li>
<li><a href="/wiki/Toronto-Dominion_Bank" title="Toronto-Dominion Bank">Toronto-Dominion Bank</a></li>
<li><a href="/wiki/TransAlta" title="TransAlta">TransAlta</a></li>
<li><a href="/wiki/TransCanada_Corp." title="TransCanada Corp." class="mw-redirect">TransCanada</a></li>
<li><strong class="selflink">Valeant</strong></li>
<li><a href="/wiki/George_Weston_Limited" title="George Weston Limited">Weston</a></li>
<li><a href="/wiki/Yamana_Gold" title="Yamana Gold">Yamana Gold</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1104
CPU time usage: 0.569 seconds
Real time usage: 0.616 seconds
Preprocessor visited node count: 2126/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 86272/2097152 bytes
Template argument size: 968/2097152 bytes
Highest expansion depth: 8/40
Expensive parser function count: 0/500
Lua time usage: 0.176/10.000 seconds
Lua memory usage: 3.05 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  444.336      1 - -total
 58.33%  259.202      1 - Template:Reflist
 27.48%  122.092     29 - Template:Cite_web
 21.35%   94.883      1 - Template:Infobox_company
 19.38%   86.128      1 - Template:Infobox
  9.95%   44.223      5 - Template:Cite_news
  4.05%   18.013      2 - Template:Navbox
  3.76%   16.696      1 - Template:Pharmaceutical_companies_of_the_United_States
  2.32%   10.314      1 - Template:NYSE
  1.94%    8.601      1 - Template:S&amp;P/TSX_60
-->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>									<div class="printfooter">
						Retrieved from "<a dir="ltr" href="http://en.wikipedia.org/w/index.php?title=Valeant_Pharmaceuticals&amp;oldid=630575249">http://en.wikipedia.org/w/index.php?title=Valeant_Pharmaceuticals&amp;oldid=630575249</a>"					</div>
													<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:S%26P/TSX_60_Index" title="Category:S&amp;P/TSX 60 Index">S&amp;P/TSX 60 Index</a></li><li><a href="/wiki/Category:S%26P/TSX_Composite_Index" title="Category:S&amp;P/TSX Composite Index">S&amp;P/TSX Composite Index</a></li><li><a href="/wiki/Category:Companies_listed_on_the_Toronto_Stock_Exchange" title="Category:Companies listed on the Toronto Stock Exchange">Companies listed on the Toronto Stock Exchange</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_of_Canada" title="Category:Pharmaceutical companies of Canada">Pharmaceutical companies of Canada</a></li><li><a href="/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange" title="Category:Companies listed on the New York Stock Exchange">Companies listed on the New York Stock Exchange</a></li><li><a href="/wiki/Category:Companies_based_in_Laval,_Quebec" title="Category:Companies based in Laval, Quebec">Companies based in Laval, Quebec</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_established_in_1960" title="Category:Pharmaceutical companies established in 1960">Pharmaceutical companies established in 1960</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Valeant+Pharmaceuticals&amp;returntoquery=diff%3D630575249%26oldid%3D628670703&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Valeant+Pharmaceuticals&amp;returntoquery=diff%3D630575249%26oldid%3D628670703" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Valeant_Pharmaceuticals"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Valeant_Pharmaceuticals"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Valeant_Pharmaceuticals" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=edit&amp;oldid=630575249"  title="You can edit this page. Please use the preview button before saving [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
														<div id="simpleSearch">
															<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />								</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
													<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
													<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
													<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
													<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
													<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
													<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
													<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
											</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
													<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
													<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
													<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
													<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
													<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
											</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
													<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Valeant_Pharmaceuticals" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
													<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Valeant_Pharmaceuticals" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
													<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
													<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
													<li id="t-permalink"><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;oldid=630575249" title="Permanent link to this revision of the page">Permanent link</a></li>
													<li id="t-info"><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;action=info" title="More information about this page">Page information</a></li>
													<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1700871" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li>
						<li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Valeant_Pharmaceuticals&amp;id=630575249" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
													<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Valeant+Pharmaceuticals">Create a book</a></li>
													<li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Valeant+Pharmaceuticals&amp;oldid=628670703&amp;writer=rdf2latex">Download as PDF</a></li>
													<li id="t-print"><a href="/w/index.php?title=Valeant_Pharmaceuticals&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
											</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
													<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Valeant" title="Valeant – German" lang="de" hreflang="de">Deutsch</a></li>
													<li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%88%D8%A7%D9%84%DB%8C%D9%86%D8%AA" title="والینت – Persian" lang="fa" hreflang="fa">فارسی</a></li>
													<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Valeant_Pharmaceuticals" title="Valeant Pharmaceuticals – French" lang="fr" hreflang="fr">Français</a></li>
													<li class="uls-p-lang-dummy"><a href="#"></a></li>
											</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a action="edit" href="//www.wikidata.org/wiki/Q1700871#sitelinks-wikipedia" text="Edit links" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-copyright"><span class="nowraplinks">This version of the page has been <a href="http://en.wikipedia.org/wiki/Wikipedia:Page_history" title="Wikipedia:Page history">revised</a>.<br /> Besides normal editing, the reason for revision may have been that this version contains factual inaccuracies, vandalism, or material not compatible with the <a href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a>.<br/></span></li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Valeant_Pharmaceuticals&amp;diff=630575249&amp;oldid=628670703&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
															<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" srcset="//bits.wikimedia.org/images/wikimedia-button-1.5x.png 1.5x, //bits.wikimedia.org/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>
													</li>
											<li id="footer-poweredbyico">
															<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.25wmf21/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//bits.wikimedia.org/static-1.25wmf21/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //bits.wikimedia.org/static-1.25wmf21/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>
													</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mediawiki.toc","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.wikiEditor.init","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.visualEditor.targetLoader","ext.eventLogging.subscriber","ext.wikimediaEvents.statsd","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":797,"wgHostname":"mw1104"});
}</script>
	</body>
</html>
